Global Hospital Care Partnering 2014 to 2021 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.
Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital Care partnering agreement structure Hospital Care partnering contract documents Top Hospital Care deals by value Most active Hospital Care dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Hospital Care dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Hospital Care dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Hospital Care deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Hospital Care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Hospital Care deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all Hospital Care partnering deals by specific Hospital Care target announced since 2014. The chapter is organized by specific Hospital Care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Hospital Care partnering and dealmaking since 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.
Report scope Global Hospital Care Partnering 2014 to 2021 is intended to provide the reader with an in-depth understanding and access to Hospital Care trends and structure of deals entered into by leading companies worldwide.
Global Hospital Care Partnering 2014 to 2021 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2014 Analysis of Hospital Care deal structure Access to headline, upfront, milestone and royalty data Access to hundreds of Hospital Care deal contract documents Comprehensive access to over 1200 Hospital Care deal records The leading Hospital Care deals by value since 2014 Most active Hospital Care dealmakers since 2014
The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other Hospital Care indications.
In Global Hospital Care Partnering 2014 to 2021, available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The Global Hospital care Partnering 2014-2021 report provides comprehensive access to available deals and contract documents for over 1200 hospital care deals. Analyzing actual contract agreements allows assessment of the following: • What are the precise rights granted or optioned? • What is actually granted by the agreement to the partner company? • What exclusivity is granted? • What is the payment structure for the deal? • How are the sales and payments audited? • What is the deal term? • How are the key terms of the agreement defined? • How are IPRs handled and owned? • Who is responsible for commercialization? • Who is responsible for development, supply, and manufacture? • How is confidentiality and publication managed? • How are disputes to be resolved? • Under what conditions can the deal be terminated? • What happens when there is a change of ownership? • What sublicensing and subcontracting provisions have been agreed? • Which boilerplate clauses does the company insist upon? • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? • Which jurisdiction does the company insist upon for agreement law?
Our reports have been used by over 10K customers, including:
Medical technology (MedTech) firms are on the verge of reinventing their role in enabling care delivery due to various external factors, such as continuous margin pressures from providers on account of increasing healthcare costs, changing needs of end users, rapid technological advancements, empowered patient-consumers taking an active role...
175 pages •
By The Business Research Company
• May 2021
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center, and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $16.948 billion in 2020 to $18.475...
The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...
The specialty vehicle market was valued at around USD 92.28 billion in 2020, and it is likely to reach USD 113.21 billion by 2026, anticipating a CAGR of 3.18% during the forecast period (2021-2026). - The economic growth in the later half of past decade (2010 - 2019) has led to the global diversification and initiation of many businesses...
KEY FINDINGS The North America patient experience management market is estimated to project a CAGR of 17.09% during the forecast period, 2021-2028. Partnerships and product launches have raised the competition in the market. Patient satisfaction has become a priority in the region in the last decade, with healthcare regulators...
Apple a day: Many operators will likely engage in mergers and acquisitions to achieve economies of scale Abstract Healthcare and Social Assistance in the US The Healthcare and Social Assistance sector has steadily grown over the past five years. The majority of services offered by subsectors in the...
Abstract Medical Supplies Manufacturing in China The Medical Supplies Manufacturing industry in China comprises manufacturers of supplementary and supporting materials and supplies for surgery and dentistry, such as medical fillers, surgical dressings, suturing materials, bandages, absorbable hemostatic materials,...
The global scintillator market reached a value of US$ 476.5 Million in 2020. Scintillators refer to materials which can absorb high-energy photons and incident particles such as protons, electrons and neutrons. The common scintillator materials include inorganic and organic crystals, organic liquids, and noble and scintillating gases. They...
397 pages •
By Global Industry Analysts
• Apr 2021
- The global market for Healthcare BPO is projected to reach US$371.2 billion by 2025, driven by the growing pressure on hospitals and healthcare organizations to reduce costs and enhance efficiency in all aspects of patient care and revenue cycle management (RCM) to survive in the era of value based care. Under...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.